Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-09-03 LOSCALZO JOSEPH Director Option exercise +16,000 $24.42 $391K 52,330
2025-09-03 LOSCALZO JOSEPH Director Sale −16,000 $60.15 $962K 36,330
2025-09-03 LOSCALZO JOSEPH Director Option exercise · Non-Qualified Stock Option (right to buy) −16,000 0
2025-09-03 Schneider Eugene EVP, Chf Clinical Develop Ofcr Option exercise 10b5-1 +19,658 $53.77 $1.1M 71,165
2025-09-03 Schneider Eugene EVP, Chf Clinical Develop Ofcr Sale 10b5-1 −12,455 $60.46 $753K 58,710
2025-09-03 Schneider Eugene EVP, Chf Clinical Develop Ofcr Sale 10b5-1 −7,203 $61.42 $442K 51,507
2025-09-03 Schneider Eugene EVP, Chf Clinical Develop Ofcr Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −19,658 0
2025-09-02 Swayze Eric EVP Research Sale 10b5-1 −10,000 $49.22 $492K 38,432
2025-09-02 Swayze Eric EVP Research Sale 10b5-1 −1,130 $53.68 $61K 37,302
2025-09-02 WENDER JOSEPH H Director Sale 10b5-1 −11,200 $55.04 $616K 125,635
2025-09-02 WENDER JOSEPH H Director Sale 10b5-1 −5,600 $57.53 $322K 120,035
2025-09-02 PARSHALL B LYNNE Director Sale 10b5-1 −10,750 $50.42 $542K 75,594
2025-09-02 PARSHALL B LYNNE Director Sale 10b5-1 −9,250 $51.49 $476K 66,344
2025-09-02 Geary Richard S EVP, Chief Development Officer Sale 10b5-1 −10,000 $50.37 $504K 79,657
2025-09-02 WENDER JOSEPH H Director Sale 10b5-1 −11,200 $55.04 $616K 125,635
2025-09-02 WENDER JOSEPH H Director Sale 10b5-1 −5,600 $57.53 $322K 120,035
2025-09-02 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise 10b5-1 +13,050 $32.60 $425K 70,180
2025-09-02 O'NEIL PATRICK R. EVP CLO & General Counsel Sale 10b5-1 −13,050 $54.51 $711K 57,130
2025-09-02 O'NEIL PATRICK R. EVP CLO & General Counsel Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 −13,050 17,517
2025-09-02 BENNETT C FRANK EVP, Chief Scientific Officer Sale 10b5-1 −5,000 $49.14 $246K 88,679

Page 27 of 34 · 668 trades